Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.

Chung EK, Posadas EM, Kasza K, Karrison T, Manchen E, Hahn OM, Stadler WM. A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. Am J Clin Oncol. 2011 Apr; 34(2):150-4.

View in: PubMed